EURASNET hosts a number of different meetings throughout the year and you can find details of forthcoming meetings below.

You can also read reports of past meetings.

Forthcoming Meetings

EURASNET Annual Reporting Meeting 2010

Meeting Location: Lisboa, Portugal
Meeting date: March 1-4, 2010

EURASNET Annual Reporting Meeting 2010
4th Reporting Period 2009

Fundação Calouste Gulbenkian, Lisboa

Coordinator: Reinhard LÜHRMANN
M.P.I. for Biophysical Chemistry, Göttingen, Germany
Meeting organisation: Maria Carmo-Fonseca¹ , Davide Gabellini² and Jean Beggs³
1 Instituto de Medicina Molecular, Universidade de Lisboa, Portugal
2 San Raffaele Scientific Institute, Italy
3 University of Edinburgh, UK

Check here for the final programme of the 2010 Lisbon EURASNET reporting meeting.

RNA Therapeutics Workshop sponsored by Harvard Medical School – Portugal Program and European Network of Excellence on Alternative Splicing, EURASNET

Meeting Location: Lisboa, Portugal
Meeting date: 4-5 March 2010

Meeting organisation: Francisco Enguita and Maria Carmo-Fonseca, Instituto de Medicina Molecular, Universidade de Lisboa, Portugal

RNA molecules have been already proven to be a key target for disease therapy as well as a tool for the development of new drugs. Since the discovery of small non-coding RNAs and all the associated phenomena like RNA interference, the possibility of using RNA-based drugs has become a subject of great interest in the pharmaceutical and clinical fields. RNA is at the core of many cellular processes and might become an outstanding landmark in the way how we will fight disease in the future.

This Workshop will join together specialists in the clinical area and in the basic experimental research within the field in a pleasant atmosphere to discuss the forthcoming and present goals of RNA therapeutics. State of the art technologies and applications of RNA molecules as drugs or targets for therapeutics will be presented by prestigious invited speakers. Topics will range from targeted delivery of RNA molecules to applications of RNAi technology, miRNAs and their antagonists, use of therapeutic aptamers, and splice-switching strategies.

The Workshop is intended for a wide audience of biomedical scientists from academia as well as industry. Students and post-docs enrolled in MD/PhD or translational research programs are particularly welcome.

We invite all interested to participate. No registration fee.
For more information, or for assistance concerning accommodation in Lisboa, please contact: patrodrigues@hmsportugal.org

Programme:

Thursday, March 4

16:00 Welcome

16:10 – 16:40 Gert Jan Van Ommen (Leiden, The Netherlands)

16:40- 17:10 Adrian Krainer (Cold Spring Harbor Laboratory, USA)

17:10 – 17:40 Mariano Garcia-Blanco (Duke University Medical Center)

17:40 – 18:10 Jamal Tazi (Institute of Molecular Genetics, Montpellier)

Friday, March 5

9:00-9:30 Tony de Fougerolles (Alnylam Pharmaceuticals, Cambridge, USA)

9:30-10:00 Haezel Pinheiro (Exiqon, Vedbaek, Denmark)

10:00-10:30 Troels Koch (Santaris Pharma, Hoersholm, Denmark)

10:30 – 11:00 Coffee break

11:00-11:30 Jörg Kaufmann (Silence Therapeutics, Berlin, Germany)

11:30-12:00 Michael P. Czech (Program in Molecular Medicine, University of Massachusetts Medical School, USA)

12:00-12:30 Sarah Fredriksson (GENOVIS, Lund, Sweden)

12:30 – 14:00 Lunch

14:00-14:30 Michael G. Kaplitt (Neurologix, New York, USA)

14:30-15:00 Sven Klussmann (NOXXON Pharma, Berlin, Germany)

15:00-15:30 Ryszard Kole (AVI BioPharma, Bothell, WA, USA)

15:30-16:00 Gary McGarrity (VIRxSYS, Gaithersburg, MD, USA)

RNA MIS-SPLICING: DISEASE & THERAPEUTICS
EURASNET INTERDISCIPLINARY FOCUS MEETING

Meeting Location:
CHURCHILL COLLEGE UNIVERSITY OF CAMBRIDGE, UK
Meeting date:
JULY 12-14, 2010

Organisers:
Chris Smith (Cambridge) & Matthew Wood (Oxford)

Description:
Errors in pre-mRNA splicing and misregulation of alternative splicing are associated with the molecular pathology of a large number of human diseases. At the same time, manipulation of pre-mRNA splicing provides opportunities for therapeutic intervention. This meeting will focus on therapeutic strategies targeting pre-mRNA splicing events. The fourteen invited speakers have been selected to provide balanced coverage of both antisense based strategies and small-molecule effectors of splicing. The scientific sessions will be held on Tuesday 13 July and the morning of Wednesday 14 July. In addition there will be a poster session on the evening of July 13. Submission of abstracts for poster presentation is invited. A small number of abstracts may also be selected for short oral presentations.

Invited Speakers:
ANNEMIEKE AARTSMA-RUS (Leiden, Netherlands)
DAVID BATES (Bristol, UK)
IRENE BOZZONI (Rome, Italy)
TOM COOPER (Houston, USA)
IAN EPERON (Leicester, UK)
BRENDAN FREY (Toronto, Canada)
YVES FROMES (Paris, France)
LUIS GARCIA (Paris, France)
ADRIAN KRAINER (Cold Spring Harbor, USA)
ANGUS LAMOND (Dundee, UK)
DANIEL SCHUMPERLI (Bern, Switzerland)
BARRIE WILKINSON (Biotica, Cambridge, UK)
MATTHEW WOOD (Oxford, UK)
JAMAL TAZI (Montpellier, France)

Bursaries are available to support medically qualified attendees
Contact: Chris Smith

Please, have a look at the meeting flier and the meeting website, where the link to the registration is provided.